By Jill Redhage
Daily Journal Staff Writer
SAN FRANCISCO - Latham & Watkins antitrust partners Karen Silverman and Al Pfeiffer scored a win for client Ovation Pharmaceuticals Inc. - now Lundbeck Inc. - last week when the Federal Trade Commission lost its lawsuit challenging Ovation's acquisitions of the pediatric heart drugs Indocin and NeoProfen. The San Francisco-based partners co-led the matter for Ovation with Chicago litigation ...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In